Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)
CNY 66.33
(-2.11%)
CNY 66.33
(-2.11%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.92 Billion CNY | 28.47% |
| 2022 | 3.04 Billion CNY | 19.7% |
| 2021 | 2.54 Billion CNY | 15.97% |
| 2020 | 2.19 Billion CNY | 30.53% |
| 2019 | 1.68 Billion CNY | 21.54% |
| 2018 | 1.38 Billion CNY | 21.31% |
| 2017 | 1.14 Billion CNY | 23.64% |
| 2016 | 922.5 Million CNY | 26.08% |
| 2015 | 731.68 Million CNY | 34.19% |
| 2014 | 545.27 Million CNY | 44.21% |
| 2013 | 378.12 Million CNY | 46.51% |
| 2012 | 258.08 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 1.2 Billion CNY | 1.58% |
| 2024 Q1 | 1.01 Billion CNY | -0.03% |
| 2024 Q2 | 1.18 Billion CNY | 16.45% |
| 2023 Q1 | 875.85 Million CNY | 16.74% |
| 2023 FY | 3.91 Billion CNY | 28.47% |
| 2023 Q4 | 1.01 Billion CNY | -2.43% |
| 2023 Q3 | 1.04 Billion CNY | 5.42% |
| 2023 Q2 | 989.32 Million CNY | 12.95% |
| 2022 FY | 3.04 Billion CNY | 19.7% |
| 2022 Q1 | 742.83 Million CNY | 14.01% |
| 2022 Q4 | 750.27 Million CNY | -14.72% |
| 2022 Q3 | 879.76 Million CNY | 30.51% |
| 2022 Q2 | 674.07 Million CNY | -9.26% |
| 2021 FY | 2.54 Billion CNY | 15.97% |
| 2021 Q4 | 651.53 Million CNY | -2.49% |
| 2021 Q3 | 668.17 Million CNY | -3.63% |
| 2021 Q1 | 532.37 Million CNY | -14.76% |
| 2021 Q2 | 693.33 Million CNY | 30.24% |
| 2020 Q1 | 288.75 Million CNY | -41.62% |
| 2020 Q4 | 624.59 Million CNY | 4.05% |
| 2020 FY | 2.19 Billion CNY | 30.53% |
| 2020 Q2 | 681.34 Million CNY | 135.96% |
| 2020 Q3 | 600.27 Million CNY | -11.9% |
| 2019 Q3 | 446.79 Million CNY | 5.11% |
| 2019 Q2 | 425.06 Million CNY | 34.89% |
| 2019 Q1 | 315.13 Million CNY | 0.0% |
| 2019 Q4 | 494.59 Million CNY | 10.7% |
| 2019 FY | 1.68 Billion CNY | 21.54% |
| 2018 FY | 1.38 Billion CNY | 21.31% |
| 2017 FY | 1.14 Billion CNY | 23.64% |
| 2016 Q1 | 196.95 Million CNY | -5.48% |
| 2016 FY | 922.5 Million CNY | 26.08% |
| 2016 Q4 | 264.3 Million CNY | 0.0% |
| 2016 Q3 | 264.3 Million CNY | 34.2% |
| 2016 Q2 | 196.95 Million CNY | 0.0% |
| 2015 Q3 | 208.37 Million CNY | 32.33% |
| 2015 Q2 | 157.46 Million CNY | -0.0% |
| 2015 Q1 | 157.46 Million CNY | 2.26% |
| 2015 Q4 | 208.37 Million CNY | 0.0% |
| 2015 FY | 731.68 Million CNY | 34.19% |
| 2014 FY | 545.27 Million CNY | 44.21% |
| 2014 Q2 | 118.64 Million CNY | 0.0% |
| 2014 Q1 | 118.64 Million CNY | 3.19% |
| 2014 Q4 | 153.99 Million CNY | 0.0% |
| 2014 Q3 | 153.99 Million CNY | 29.79% |
| 2013 Q2 | 74.07 Million CNY | 0.0% |
| 2013 Q4 | 114.98 Million CNY | 0.0% |
| 2013 FY | 378.12 Million CNY | 46.51% |
| 2013 Q3 | 114.98 Million CNY | 55.21% |
| 2013 Q1 | 74.07 Million CNY | 0.0% |
| 2012 FY | 258.08 Million CNY | 0.0% |